We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-2.54%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$49.4B
AUM Growth
-$1.83B
Cap. Flow
+$236M
Cap. Flow %
0.48%
Top 10 Hldgs %
23.11%
Holding
2,899
New
506
Increased
652
Reduced
806
Closed
772

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.93B
2
KVUE icon
Kenvue
KVUE
+$537M
3
HUM icon
Humana
HUM
+$477M
4
ABBV icon
AbbVie
ABBV
+$441M
5
MSFT icon
Microsoft
MSFT
+$384M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$747M
2
AAPL icon
Apple
AAPL
+$565M
3
ATVI
Activision Blizzard
ATVI
+$467M
4
MCK icon
McKesson
MCK
+$347M
5
INTC icon
Intel
INTC
+$300M

Sector Composition

Rank Sector Weight
1 Technology 19.79%
2 Healthcare 17.06%
3 Consumer Discretionary 12.96%
4 Consumer Staples 7.45%
5 Financials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCI icon
1226
Crown Castle
CCI
$32.4B
$1.9M ﹤0.01%
20,637
-138,728
-87% -$14.4M
ASHR icon
1227
PUT
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.57B
$1.9M ﹤0.01%
+72,900
New +$1.95M
INBX
1228
DELISTED
Inhibrx, Inc. Common Stock
INBX
$1.89M ﹤0.01%
103,243
+91,550
+783% +$1.92M
OFIX icon
1229
Orthofix Medical
OFIX
$476M
$1.89M ﹤0.01%
+146,914
New +$2.64M
HRTG icon
1230
Heritage Insurance Holdings
HRTG
$871M
$1.89M ﹤0.01%
291,041
+214,796
+282% +$1.05M
RDY icon
1231
Dr. Reddy's Laboratories
RDY
$9.88B
$1.88M ﹤0.01%
140,735
-1,093,825
-89% -$14.8M
AVPTW
1232
CALL
DELISTED
AvePoint Inc Warrant
AVPTW
$1.88M ﹤0.01%
280,000
-3,070
-1% -$2.98K
MORN icon
1233
Morningstar
MORN
$7B
$1.87M ﹤0.01%
+8,000
New +$1.81M
SCPL
1234
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$1.87M ﹤0.01%
82,148
-21,752
-21% -$467K
ACIW icon
1235
ACI Worldwide
ACIW
$5.9B
$1.87M ﹤0.01%
82,855
BF.B icon
1236
Brown-Forman Class B
BF.B
$12.5B
$1.87M ﹤0.01%
32,340
-110,929
-77% -$7.38M
CDMO
1237
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1.86M ﹤0.01%
196,991
-7,583
-4% -$91.3K
AN icon
1238
AutoNation
AN
$7.1B
$1.86M ﹤0.01%
+12,266
New +$1.96M
OBE
1239
Obsidian Energy
OBE
$662M
$1.86M ﹤0.01%
225,846
+123,655
+121% +$865K
BLNK icon
1240
Blink Charging
BLNK
$78.6M
$1.85M ﹤0.01%
+605,100
New +$3.04M
XME icon
1241
State Street SPDR S&P Metals & Mining ETF
XME
$3.9B
$1.83M ﹤0.01%
+34,906
New +$1.81M
CMG icon
1242
CALL
Chipotle Mexican Grill
CMG
$42.6B
$1.83M ﹤0.01%
50,000
-210,000
-81% -$8.19M
ARCE
1243
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$1.83M ﹤0.01%
+132,860
New +$1.75M
RSI icon
1244
Rush Street Interactive
RSI
$3.27B
$1.82M ﹤0.01%
394,355
+240,286
+156% +$1.01M
FHI icon
1245
Federated Hermes
FHI
$4.48B
$1.82M ﹤0.01%
53,700
-134,546
-71% -$4.63M
DAR icon
1246
Darling Ingredients
DAR
$9.57B
$1.81M ﹤0.01%
34,718
-8,581
-20% -$536K
MDU icon
1247
MDU Resources
MDU
$4.38B
$1.81M ﹤0.01%
+166,981
New +$1.92M
XLG icon
1248
Invesco S&P 500 Top 50 ETF
XLG
$10.4B
$1.81M ﹤0.01%
+53,291
New +$1.87M
OSI.WS
1249
CALL
DELISTED
Osiris Acquisition Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OSI.WS
$1.81M ﹤0.01%
174,997
HPLTW
1250
CALL
DELISTED
Home Plate Acquisition Corporation Warrant
HPLTW
$1.81M ﹤0.01%
171,805

Similar funds

Marshall Wace's Q3 2023 Portfolio in Review

As of Q3 2023, Marshall Wace held 2,899 positions worth $49.4B, down 3.6% from $51.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Marshall Wace's Q3 2023 filing shows 506 new, 652 increased, 806 reduced and 772 closed positions. Its largest new stake was Humana: 1,014,185 shares worth $493M. The largest sale was Amazon, an estimated $747M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q3 2023 buy was Humana: 1,014,185 shares worth $493M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $1.93B increase.
  • Marshall Wace's biggest Q3 2023 reduction was Amazon, cutting an estimated $747M.
  • Marshall Wace fully exited Johnson & Johnson in Q3 2023, selling an estimated $284M.
  • Marshall Wace's ten largest holdings make up 23% of its $49.4B portfolio in Q3 2023.
  • Marshall Wace opened 506 new positions and closed 772 in Q3 2023.
  • Marshall Wace's portfolio value fell 3.6% quarter-over-quarter to $49.4B.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.